Arrowhead Research | Der Umsatz



Sales Veränderung Datum
Agios Pharmaceuticals USD 10.73M 1.77M 2024-12
Alnylam Pharmaceuticals USD 593.17M 92.25M 2024-12
Arrowhead Research USD 2.5M 2.5M 2024-12
Incyte USD 1.18B 40.83M 2024-12
Ionis Pharmaceuticals USD 226.58M 92.76M 2024-12
Ligand Pharmaceuticals USD 42.81M 9M 2024-12
Merck USD 15.62B 1.03B 2024-12
Moderna USD 966M 896M 2024-12
Novartis USD 13.15B 330M 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
TG Therapeutics USD 108.18M 24.31M 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12
Xencor USD 70.02M 59.31M 2024-12



Arrowhead Research Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.